Does Colorado Medicaid Cover Weight Loss Medication?

Colorado Medicaid does not cover weight loss medication when it is prescribed only to lose weight. As of the January 2026 Preferred Drug List, Health First Colorado will deny any prior authorization for a GLP-1 drug requested solely for weight loss.1Colorado Department of Health Care Policy and Financing. Preferred Drug List January 1, 2026 Two medications, Wegovy and Zepbound, can still be approved when they are tied to a specific covered condition, and broader coverage is on the way through state legislation and a new federal model.

The blanket restriction is where most people stop reading and assume they have no options. The exceptions are narrow, but real, and knowing exactly how to frame a request is the difference between a denial and a filled prescription.

Wegovy for Cardiovascular Risk

Wegovy (semaglutide) is on the Preferred Drug List with its own criteria, separate from the weight-loss restriction. It is approved to reduce the risk of heart attack and stroke in people who are also overweight, not to treat weight as a standalone goal. All of the following must be true:1Colorado Department of Health Care Policy and Financing. Preferred Drug List January 1, 2026

  • You are 18 or older.
  • You have established cardiovascular disease — a history of heart attack, stroke, or symptomatic peripheral arterial disease.
  • Your BMI is 25 or higher.
  • You do not have Type 2 diabetes. If you do, other GLP-1 medications like Ozempic are covered for that condition instead.
  • The prescription is specifically to reduce the risk of cardiovascular events.
  • You have been counseled on diet and exercise.

If your doctor can document every one of these, this is the most accessible current path to Medicaid-covered semaglutide.

Zepbound for Sleep Apnea

Zepbound (tirzepatide) is listed as non-preferred, which means extra scrutiny, but it can be approved for moderate to severe obstructive sleep apnea. The criteria are stricter:1Colorado Department of Health Care Policy and Financing. Preferred Drug List January 1, 2026

  • You are 18 or older.
  • You have moderate to severe obstructive sleep apnea confirmed by an FDA-approved sleep test, with an Apnea-Hypopnea Index of 15 or more events per hour.
  • Your BMI is 30 or higher.
  • You have tried CPAP therapy for at least six months without success, or you have a medical reason you cannot use it.
  • The prescription comes from, or in consultation with, a neurologist, pulmonologist, or other sleep medicine specialist.
  • You have no personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2, and you are not pregnant or planning to become pregnant.
  • You have been counseled on diet and exercise to promote weight loss.

A baseline sleep study must accompany the prior authorization request. This pathway is narrow, and most people looking for a weight loss medication will not qualify through it.

How to Get Prior Authorization Approved

Every weight-related GLP-1 on the Preferred Drug List requires prior authorization. Your prescribing doctor starts the process by contacting Health First Colorado at 1-800-424-5725.2Health First Colorado. My Pharmacy Told Me My Medication Is Denied Because a Prior Authorization Was Needed – What Should I Do? The request needs clinical documentation covering your BMI, the relevant diagnosis, and any required test results such as a sleep study for Zepbound. Processing takes up to 24 hours.3Health First Colorado. Pharmacy Benefits Frequently Asked Questions

The most common reason a prior authorization fails is that the paperwork describes the prescription as being for weight loss rather than for the specific approved indication. Your doctor’s notes need to connect the medication directly to cardiovascular risk reduction or to sleep apnea, depending on which drug is being requested. If your pharmacy tells you the medication was denied because no prior authorization was on file, ask your doctor’s office to submit one and return the following day.

If your prescription is approved, you will pay nothing at the pharmacy. Since July 1, 2023, Health First Colorado members have no copays for any covered prescription drug.4Colorado Department of Health Care Policy and Financing. Health First Colorado Pharmacy Benefits

Appealing a Denial

If prior authorization is denied, you can appeal. The denial letter, called a Notice of Action, explains the reasons and the next steps.5Health First Colorado. Appeals If you are in a managed care plan, you typically start by appealing to your health plan or the company handling your pharmacy benefits. Deadlines vary, so follow the letter carefully. If your plan had previously authorized a service and then stopped or reduced it, you can ask for benefits to continue during the appeal by contacting your plan within 10 days of the date on the letter.

If the plan-level appeal fails, you can request a state fair hearing through the Office of Administrative Courts. You generally have 60 days from the date on your Notice of Action to file. To keep benefits running while the hearing is pending, the Office of Administrative Courts must receive your request within 10 days of the plan’s final decision. Before the hearing, gather any additional records your doctor can provide that tie the medication to a covered diagnosis rather than to weight loss alone.

Coverage That Could Expand in 2026

Two developments could change the answer to this question later in the year.

The Colorado legislature passed SB 25-048, the Diabetes Prevention and Obesity Treatment Act, which directs the Department of Health Care Policy and Financing to cover weight-loss medication to treat obesity, along with screenings, behavioral and lifestyle therapy, and bariatric surgery.6Colorado General Assembly. SB 25-048 Diabetes Prevention and Obesity Treatment Act – Fiscal Note Until HCPF updates its formulary and prior authorization criteria to reflect the law, the practical experience at the pharmacy stays what it is today. Check the Preferred Drug List on the HCPF website periodically for updates.

Separately, the Centers for Medicare and Medicaid Services launched the BALANCE model (Better Approaches to Lifestyle and Nutrition for Comprehensive Health), which lets state Medicaid agencies opt in starting May 2026. Under BALANCE, CMS negotiates lower GLP-1 prices directly with manufacturers for participating states, and the covered drugs include all formulations of Mounjaro, Ozempic, Rybelsus, Wegovy, the KwikPen formulation of Zepbound, and potentially orforglipron if the FDA approves it.7Centers for Medicare & Medicaid Services. BALANCE Model Eligibility is broader than the current Colorado PDL allows: adults with a BMI of 35 or higher, a BMI of 30 with a qualifying condition such as heart failure with preserved ejection fraction, uncontrolled hypertension, chronic kidney disease stage 3a or above, or moderate to severe obstructive sleep apnea, or a BMI of 27 with pre-diabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease. Beneficiaries who receive a GLP-1 through BALANCE also get a manufacturer-provided lifestyle support program at no cost.

States have until July 31, 2026, to respond to the request for applications. Colorado has not publicly confirmed whether it will opt in, though the General Assembly is studying GLP-1 coverage options.